Biosensors is a medical devices designed primarily for the detection or measurement of biological substances like biomolecules or microorganisms. These analytical tools are capable of converting biological responses into electrical signals. Comprising three essential components namely, an analyte-identifying unit generating signals, a signal transducer, and a reader device biosensors have diverse applications in areas such as food and beverages, environmental monitoring, and home care diagnostics. They are also utilized in nanomechanical biosensors. Furthermore, biosensor applications extend to plant biology, where they play a crucial role in studying metabolic processes.
The global Biosensors market was valued at approximately USD 26.4 billion in 2022 and it is anticipated to grow further to nearly USD 51.5 billion by 2032, at a CAGR of 6.9% during the forecast period.
Download Research Report Sample & TOC:
https://www.globalinsightservices.com/request-sample/GIS21189/
(We are providing report as per your research requirement, including the Latest Industry Insight’s Evolution and Potential)
- 11 – Chapter
- 459 – Pages
- Industry: Semiconductors & Electronics
Key trends:
The biosensors market is experiencing significant growth driven by a surge in demand for portable biosensors in the Asia Pacific and European regions. The increasing awareness of the importance of rapid and accurate diagnostics, coupled with the growing prevalence of chronic diseases, has fueled the adoption of biosensors. The portability of these devices offers a convenient and efficient solution for point-of-care testing, enabling healthcare professionals to quickly obtain real-time information. Additionally, the rise in health-conscious consumers and the need for continuous monitoring further contribute to the market expansion. As these regions continue to prioritize advancements in healthcare technology, the biosensors market is poised for sustained growth, with portable biosensors playing a pivotal role in shaping the industry landscape.
Get Customized Reports with your Requirements:
https://www.globalinsightservices.com/request-customization/GIS21189
Market Segmentation:
By Type:
It is segmented into wearable, and non-wearable. The non-wearable segment in the biosensors market has experienced robust growth driven by technological advancements and increasing applications across diverse industries. Non-wearable biosensors, which include implantable sensors, ingestible sensors, and environmental sensors, have witnessed heightened demand in areas such as healthcare, agriculture, and environmental monitoring. The growing emphasis on continuous, real-time data monitoring and the integration of biosensors into various non-traditional platforms contribute to the segment’s expansion. Additionally, the focus on miniaturization, enhanced sensitivity, and improved communication capabilities further propels the non-wearable biosensors market.
By Application:
It is segmented into Blood Glucose Testing, Cholesterol Testing, Blood Gas Analysis, Pregnancy Testing, Drug Discovery, Infectious Disease Testing, and others. The Infectious Disease Testing segment within the biosensors market is experiencing robust growth, driven by an increasing demand for rapid and accurate diagnostic solutions. Biosensors play a pivotal role in detecting infectious diseases by leveraging their ability to detect specific biomolecules associated with pathogens. The ongoing global focus on public health, coupled with the need for timely disease identification, has propelled the adoption of biosensor-based infectious disease testing.
Inquiry before Buying:
https://www.globalinsightservices.com/inquiry-before-buying/GIS21189
Data Summary:
Report Attribute |
Details |
| Market Size in 2022 | US$ 26.4 Billion |
| Market Size in 2032 | US$ 51.5 Billion |
| CAGR % | 6.9% |
| Historic Period | 2016-2021 |
| Forecast Period | 2023-2032 |
| Base Year | 2022 |
| Segments Covered | Type, Technology, Application, End-user, and Region. |
| Key Companies | Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Ascensia Diabetes Care Holdings AG, Biosensors International Group, Ltd, Siemens Healthineers AG, Bio-Rad Laboratories, Inc, among others. |
| Regional Scope | North America, Europe, Asia Pacific, Central & South America, Middle East & Africa |
| Analysis Coverage | Market Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments |
Recent Developments
- In January 2023, Intricon Corporation announced the opening of a Bionsensor Center of Excellence (CoE). The center aims to vertically integrate the company’s business to provide biosensors in medical devices.
- In May 2020, Philips has received FDA clearance for its wearable biosensor, the Philips Biosensor BX100, designed to assist in managing confirmed and suspected COVID-19 patients in hospitals. This wireless biosensor, already in use at the OLVG Hospital in the Netherlands, enhances clinical surveillance by detecting vital signs and supporting early intervention for patients in lower acuity care areas. The disposable biosensor, with a 5-day usage cycle, adheres discreetly to the chest, transmitting respiratory and heart rates, along with contextual parameters, without the need for cleaning or charging. The device is part of Philips’ patient deterioration detection solution, providing a scalable and integrated approach to monitoring multiple patients across various rooms.
Procure Complete Report (459 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.globalinsightservices.com/checkout/single_user/GIS21189
Key Players:
- Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Siemens Healthineers AG
- Ascensia Diabetes Care Holdings AG
- Bio-Rad Laboratories, Inc
- Biosensors International Group, Ltd
- Dexcom, Inc.
- LifeScan Inc.
- Masimo
By Region
- North America (U.S., Canada, Mexico)
- Europe (UK, Germany, France, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, India, South Korea, Rest of Asia-Pacific)
- Latin America (Brazil, Argentina, Rest of Latin America)
- Middle East and Africa (UAE, Saudi Arabia, Rest of Middle East And Africa)
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Infographic excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Us:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.